Search for tasp0382088 in research

Discovery of 7-Methoxy-6-[4-(4-Methyl-1,3-Thiazol-2-yl)-1H-Imidazol-5-yl]-1,3-Benzothiazole (TASP0382088): A Potent and Selective Transforming Growth Factor-β Type I Receptor Inhibitor as a Topical Drug for Alopecia

research Discovery of 7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1<i>H</i>-imidazol-5-yl]-1,3-benzothiazole (TASP0382088): A Potent and Selective Transforming Growth Factor-β Type I Receptor Inhibitor as a Topical Drug for Alopecia

6 citations , January 2013 in “Chemical & pharmaceutical bulletin/Chemical and pharmaceutical bulletin”

A new compound shows promise as a topical treatment for hair loss.

research Therapeutic potential of endogenous stem cells and cellular factors for scar-free skin regeneration

9 citations , November 2018 in “Drug Discovery Today”

Using skin stem cells and certain molecules might lead to scar-free skin healing.

research Finasteride 98319‐26‐7

October 2012 in “Sax's Dangerous Properties of Industrial Materials”

research POSTTEST: EXPIRATION DATE: OCTOBER 2011

October 2010 in “JAAPA”

research 842Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS)

March 2005 in “European Urology Supplements”

research 96/06363 Flash co-pyrolysis of coal retaining depolymerized polyethylene as radical donor

November 1996 in “Fuel and Energy Abstracts”

research Tebentafusp-tebn (Kimmtra®)

March 2022 in “Oncology Times”

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

research Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial

3 citations , February 2019 in “Molecular genetics and metabolism”

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

research 63748 Combined Regenerative Technique: A New Therapeutical Option for Androgenetic Alopecia

September 2025 in “Journal of the American Academy of Dermatology”

research BindingDB Entry 50021519: Discovery of (2S)-N-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment.

January 2025

Comprehensive Program Planning for the Integration of 21st Century Learning Center After-School Programs with Regular Day Programs and Community Partners

research Comprehensive Program Planning for the Integration of 21st Century Learning Center After-School Programs with Regular Day Programs and Community Partners.

January 1999 in “American Journal of Medical Genetics Part A”

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

research 0955 Selective BET inhibition as potential hidradenitis suppurativa treatment

July 2025 in “Journal of Investigative Dermatology”

research Contents Vol. 207, 2003

January 2003 in “Dermatology”

research Erratum

January 2024 in “Skin Appendage Disorders”

research Erratum

October 2002 in “Dermatologic Surgery”

research The Efficacy and Safety of AP-FHG0604T on Female Pattern Hair Loss: A Randomized Double-blind Placebo-controlled Clinical Trial

February 2007 in “Journal of Clinical Dermatology”

research Identification of 736T>A mutation of lipase H in Japanese siblings with autosomal recessive woolly hair

7 citations , February 2011 in “Journal of dermatology”

The 736T>A mutation in the LIPH gene is common in Japanese people with autosomal recessive woolly hair.

research Tissue Laxity Based on Donor Tissue Ballooning

10 citations , July 2001 in “Hair transplant forum international”

The document's conclusion cannot be provided because the document is not readable or understandable.

Single Nucleotide Polymorphisms Associated with Elevated Alanine Aminotransferase in Patients Receiving Asunaprevir Plus Daclatasvir Combination Therapy for Chronic Hepatitis C

research Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C

2 citations , July 2019 in “PLOS ONE”

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Unusual Systemic Lupus Erythematosus/Sjogren's Syndrome Phenotype in a Patient with a TNFAIP3 Gene Mutation

research SAT0200 UNUSUAL SYSTEMIC LUPUS ERYTHEMATOSUS/SJOEGREN'S SYNDROME PHENOTYPE IN A PATIENT WITH A TNFAIP3 GENE MUTATION

June 2019

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

research 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata

July 2024 in “Journal of Investigative Dermatology”

research Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer

February 2026 in “Oncology Reviews”

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

research Contents Vol. 240, 2024

December 2024 in “Dermatology”

Association of Rs231775 Genetic Variant of Cytotoxic T-Lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case-Control Study

research Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case–Control Study

7 citations , July 2020 in “Immunological Investigations”

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

research A frameshift mutation in HTRA1 expands CARASIL syndrome and peripheral small arterial disease to the Chinese population

21 citations , March 2015 in “Neurological Sciences”

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

Search

for
Search:

Research

research Discovery of 7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1<i>H</i>-imidazol-5-yl]-1,3-benzothiazole (TASP0382088): A Potent and Selective Transforming Growth Factor-β Type I Receptor Inhibitor as a Topical Drug for Alopecia

research Therapeutic potential of endogenous stem cells and cellular factors for scar-free skin regeneration

research Finasteride 98319‐26‐7

research POSTTEST: EXPIRATION DATE: OCTOBER 2011

research 842Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS)

research 96/06363 Flash co-pyrolysis of coal retaining depolymerized polyethylene as radical donor

research Tebentafusp-tebn (Kimmtra®)

research Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial

research 63748 Combined Regenerative Technique: A New Therapeutical Option for Androgenetic Alopecia

research BindingDB Entry 50021519: Discovery of (2S)-N-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment.

research Comprehensive Program Planning for the Integration of 21st Century Learning Center After-School Programs with Regular Day Programs and Community Partners.

research 0955 Selective BET inhibition as potential hidradenitis suppurativa treatment

research Contents Vol. 207, 2003

research Erratum

research Erratum

research The Efficacy and Safety of AP-FHG0604T on Female Pattern Hair Loss: A Randomized Double-blind Placebo-controlled Clinical Trial

research Identification of 736T>A mutation of lipase H in Japanese siblings with autosomal recessive woolly hair

research Tissue Laxity Based on Donor Tissue Ballooning

research Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C

research SAT0200 UNUSUAL SYSTEMIC LUPUS ERYTHEMATOSUS/SJOEGREN'S SYNDROME PHENOTYPE IN A PATIENT WITH A TNFAIP3 GENE MUTATION

research 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata

research Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer

research Contents Vol. 240, 2024

research Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case–Control Study

research A frameshift mutation in HTRA1 expands CARASIL syndrome and peripheral small arterial disease to the Chinese population

research ISID1116 – Novel androgen receptor degrader for androgenetic alopecia (AGA) application

research 50842 Mohs micrographic surgery for nail-unit squamous cell carcinoma

research DNMT3B -579G>T POLYMORPHİSM AND THE RİSK OF COLORECTAL CANCER IN AZERBAİJAN POPULATİON

research Tissue Dynamics in the Three-Hair-Bearing Flap Transposition

research P0881 Effectiveness and Safety of Tofacitinib in Biologic-Naïve Elderly Patients with Ulcerative Colitis